Targeting endosomal pH for cancer chemotherapy

Mol Cell Oncol. 2018 Mar 13;5(3):e1435184. doi: 10.1080/23723556.2018.1435184. eCollection 2018.

Abstract

Altered pH homeostasis in cancer cells has been linked with essentially all classical hallmarks of cancer, including chemoresistance. We recently identified a conceptually novel mechanism for how dysregulated pH in hypoxic cells causes chemoresistance which is based on the aberrant cellular distribution of the endosomal pH regulator, the sodium/hydrogen exchanger 6 (NHE6).

Keywords: NHE6; Solute Carrier Family 9 Member A6 (SLC9A6); chemoresistance; drug partitioning; endosomes; pH-regulation.

Grants and funding

This work was supported by the Canadian Institute of Health research, (MOP-126173) and an internal (UdeS/Merck Sharp & Dohme) operating grant.